Device Trial Radar · NCT03997994
DIGEST I Drug Coated Balloon for Biliary Stricture
Last checked: Nov 20, 2026Latest source record: Aug 17, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
8
Actual
Start
May 12, 2019
Primary completion
Mar 21, 2024
Study completion Mar 21, 2025
Sponsor
- Lead sponsor
- GIE MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 25, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
DIGEST I Pilot study is a feasibility study for evaluating the safety and efficacy of DCBs.
Conditions
- Biliary Stricture
- Biliary Anastomotic Stenosis
- Biliary Obstruction
- Biliary Disease
Interventions
GIE Drug Coated BalloonDevice
The GIE DCB is a balloon catheter coated with a proprietary coating containing the drug and carriers.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incident of serious balloon dilation-related complicationsTime frame: 30 days
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Adventista Hospital
Asunción, Paraguay
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.